Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Biomarkers

Screening for C-reactive protein in CVD prediction

Nature Reviews Cardiology volume 10, pages 12–14 (2013)Cite this article

Subjects

Adding C-reactive protein (CRP) level to conventional cardiovascular risk models has been suggested to improve risk prediction for cardiovascular events. However, evaluation of the potential impact of CRP measurement in cardiovascular risk management will require studies designed to quantify the effect of additional CRP assessment on medical decision-making, patient outcomes, and cost-effectiveness.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. D'Agostino, R. B. Sr et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743–753 (2008).

    Article  Google Scholar 

  2. Greenland, P. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 56, e50–e103 (2010).

    Article  Google Scholar 

  3. Genest, J. et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can. J. Cardiol. 25, 567–579 (2009).

    Article  CAS  Google Scholar 

  4. Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N. Engl. J. Med. 367, 1310–1320 (2012).

  5. Brautbar, A. et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities Study. Circ. Cardiovasc. Genet. 2, 279–285 (2009).

    Article  CAS  Google Scholar 

  6. Den Ruijter, H. M. et al. Common carotid intima–media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 308, 796–803 (2012).

    Article  CAS  Google Scholar 

  7. Kavousi, M. et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann. Intern. Med. 156, 438–444 (2012).

    Article  Google Scholar 

  8. Polonsky, T. S. et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303, 1610–1616 (2010).

    Article  CAS  Google Scholar 

  9. Vickers, A. J. & Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making 26, 565–574 (2006).

    Article  Google Scholar 

  10. Moons, K. G., Altman, D. G., Vergouwe, Y. & Royston, P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338, b606 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6.131, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands

    Sanne A. E. Peters & Diederick E. Grobbee

  2. Department of Vascular Medicine, University Medical Center Utrecht, Stratenum 6.131, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands

    Frank L. J. Visseren

Authors
  1. Sanne A. E. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank L. J. Visseren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diederick E. Grobbee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanne A. E. Peters.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peters, S., Visseren, F. & Grobbee, D. Screening for C-reactive protein in CVD prediction. Nat Rev Cardiol 10, 12–14 (2013). https://doi.org/10.1038/nrcardio.2012.164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2012.164

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research